Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Low-dose spironolactone and cardiovascular outcomes in moderate stage Chronic Kidney Disease: a randomised controlled trial

HOBBS R. et al, (2024), Nature Medicine

NHS reference costs: a history and cautionary note.

Amies-Cull B. et al, (2023), Health Econ Rev, 13

The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme)

Wang K. et al, (2023), Programme Grants for Applied Research, 1 - 57

Protocol for the TRANSLATE prospective, multi-centre, randomised clinical trial.

Bryant RJ. et al, (2023), BJU Int

Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.

Jones DA. et al, (2023), Clin Oncol (R Coll Radiol)

TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.

Thomson DJ. et al, (2023), Clin Transl Radiat Oncol, 38, 147 - 154

Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial.

Hill NR. et al, (2022), Trials, 23

Quality of life in older adults with chronic kidney disease and transient changes in renal function: findings from the Oxford Renal Cohort

HOBBS F. et al, (2022), PLoS One

Estimating BMI distributions by age and sex for local authorities in England: a small area estimation study

Amies-Cull B. et al, (2022), BMJ Open, 12, e060892 - e060892

Quality of life, healthcare use and costs in 'at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: within-trial descriptive economic analyses of the ARCHIE randomised controlled trial.

Rombach I. et al, (2022), BMJ Open, 12

Small area estimates of BMI by age, sex and lower tier local authority (England)

Amies-Cull B. et al, (2022)

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial.

Lorenc A. et al, (2022), Clin Oncol (R Coll Radiol), 34, 230 - 240

The costs of bipolar disorder in the United Kingdom.

Simon J. et al, (2021), Brain Behav, 11

Survival, Dependency, and Health-Related Quality of Life in Patients With Ruptured Intracranial Aneurysm: 10-Year Follow-up of the United Kingdom Cohort of the International Subarachnoid Aneurysm Trial (ISAT)

Hua X. et al, (2021), NEUROSURGERY, 89, S81 - S81

Survival, dependency and health-related quality of life in patients with ruptured intracranial aneurysm: ten-year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT)

HUA X. et al, (2020), Neurosurgery

Improving outcomes for women diagnosed with early breast cancer through Adherence to adjuvant endocrine therapy (SWEET)

Sharp L. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 544 - 545

Quality of life in the FOXFIRE, SIRFLOX, and FOXFIRE-Global randomised trials of selective internal radiotherapy for metastatic colorectal cancer

WOLSTENHOLME J. et al, (2019), International Journal of Cancer

The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial.

Harvie M. et al, (2019), Br J Cancer

Estimating the cost-effectiveness of salt reformulation and increasing access to leisure centres in England, with PRIMEtime CE model validation using the AdViSHE tool.

Briggs A. et al, (2019), BMC Health Services Research

PRIMEtime CE: a multistate life table model for estimating the cost-effectiveness of interventions affecting diet and physical activity

Briggs A. et al, (2019), BMC Health Services Research

Load More

Handbooks in Health Economic Evaluation

A series published by Oxford University Press.

Find out more